The limitations of targeting telomerase, and the fact that telomerase inhibition would not affect cancer cells using the ALT pathway, encouraged researchers to investigate alternative therapeutic approaches targeting telomeres in a telomerase- and telomere length-independent manner. This evidence concerns the gene GPT and cancer.